Lantus solostar insulin 10ml.vial

The Lantus solostar insulin 10ml.vial Cartridge System is an innovative delivery system for the long-acting sort of the hormone insulin. Insulin helps control the quantity of sugar present within the body by reducing the quantity of glucose within the blood, a treatment commonly related to diabetes. This delivery system is employed to enhance glycemic control in both adults and kids diagnosed with type 1 diabetes, also as in adults diagnosed with type 2 diabetes.

Lantus is contraindicated in patients who are hypersensitive to insulin glargine or one among its components. Lantus should never be diluted or mixed with the other insulin compound or solution, because the solution may become cloudy, and this will significantly affect the onset of action of the answer. don't use the other method to administer Lantus, like an insulin pump or intravenously because severe hypoglycemia may occur. Remember that insulin devices and needles should never be shared with other patients. blood sugar levels in patients treated with insulin should be closely monitored for any significant changes. A sudden drop in blood glucose levels can indicate hypoglycemia, which may be dangerous.

Uses and dosage :

Adults and Children:

Give by SC inj once daily at same time each day into abdominal area, thigh, or deltoid; rotate inj sites. Onset one .1hrs, no pronounced peak, duration 24hrs or longer. <6yrs: not established. ≥6yrs: individualize; monitor and adjust as needed. Type 1 diabetes: Initially ⅓ of total daily insulin dose. Give remainder of the total dose as short-acting, premeal insulin. Insulin-naïve with type 2 diabetes: Initially 0.2 Units per kg or up to 10 Units once daily. May need to adjust amount, timing of short- or rapid-acting insulins and doses of any oral antidiabetics. Switching from once-daily Toujeo (insulin glargine 300 Units/mL): reduce initial Lantus dose by 20% of the previous Toujeo dose. Switching from a long- or intermediate-acting insulin regimen: may need to change basal insulin dose; and adjust the amount, timing of the short-acting insulins and doses of any oral antidiabetics. Switching from once-daily NPH: initial Lantus dose should be the same as previous NPH dose. Switching from twice-daily NPH: reduce initial Lantus dose by 20% of the previous total NPH dose.